Elevance Health Return on Investment 2010-2025 | ELV
Current and historical return on investment (ROI) values for Elevance Health (ELV) over the last 10 years.
| Elevance Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $9.03B | $70.73B | 13.04% |
| 2024-12-31 | $9.09B | $70.64B | 13.53% |
| 2024-09-30 | $9.40B | $68.57B | 14.42% |
| 2024-06-30 | $9.64B | $66.86B | 15.14% |
| 2024-03-31 | $9.08B | $62.69B | 14.46% |
| 2023-12-31 | $8.75B | $62.65B | 13.93% |
| 2023-09-30 | $8.76B | $62.58B | 14.18% |
| 2023-06-30 | $9.19B | $63.17B | 15.20% |
| 2023-03-31 | $8.81B | $62.66B | 14.96% |
| 2022-12-31 | $8.45B | $58.68B | 14.77% |
| 2022-09-30 | $8.86B | $57.30B | 15.58% |
| 2022-06-30 | $8.72B | $57.03B | 15.31% |
| 2022-03-31 | $8.95B | $55.91B | 15.70% |
| 2021-12-31 | $8.81B | $57.29B | 15.42% |
| 2021-09-30 | $7.93B | $57.57B | 14.18% |
| 2021-06-30 | $6.35B | $57.26B | 11.59% |
| 2021-03-31 | $7.14B | $56.45B | 13.21% |
| 2020-12-31 | $7.06B | $52.53B | 13.41% |
| 2020-09-30 | $7.55B | $53.02B | 14.54% |
| 2020-06-30 | $8.60B | $54.33B | 16.81% |
| 2020-03-31 | $6.89B | $50.70B | 13.87% |
| 2019-12-31 | $6.73B | $49.52B | 13.79% |
| 2019-09-30 | $6.17B | $50.15B | 12.88% |
| 2019-06-30 | $5.92B | $48.23B | 12.62% |
| 2019-03-31 | $5.98B | $47.39B | 12.88% |
| 2018-12-31 | $5.83B | $45.76B | 12.71% |
| 2018-09-30 | $5.68B | $46.39B | 12.50% |
| 2018-06-30 | $5.52B | $46.24B | 12.61% |
| 2018-03-31 | $5.22B | $45.12B | 12.26% |
| 2017-12-31 | $4.99B | $43.89B | 11.96% |
| 2017-09-30 | $5.25B | $39.73B | 12.95% |
| 2017-06-30 | $5.29B | $41.52B | 13.10% |
| 2017-03-31 | $5.53B | $41.54B | 13.96% |
| 2016-12-31 | $5.28B | $39.46B | 13.59% |
| 2016-09-30 | $4.99B | $38.99B | 12.94% |
| 2016-06-30 | $4.97B | $38.44B | 12.90% |
| 2016-03-31 | $5.05B | $38.41B | 13.09% |
| 2015-12-31 | $5.28B | $38.37B | 13.62% |
| 2015-09-30 | $5.77B | $38.96B | 14.90% |
| 2015-06-30 | $5.79B | $38.53B | 14.98% |
| 2015-03-31 | $5.50B | $39.10B | 14.22% |
| 2014-12-31 | $5.05B | $38.27B | 13.13% |
| 2014-09-30 | $4.62B | $38.83B | 12.02% |
| 2014-06-30 | $4.48B | $38.42B | 11.62% |
| 2014-03-31 | $4.43B | $38.28B | 11.47% |
| 2013-12-31 | $4.59B | $38.34B | 11.87% |
| 2013-09-30 | $4.60B | $39.32B | 11.92% |
| 2013-06-30 | $4.58B | $38.62B | 12.04% |
| 2013-03-31 | $4.39B | $38.35B | 11.91% |
| 2012-12-31 | $4.37B | $37.97B | 12.40% |
| 2012-09-30 | $4.34B | $37.21B | 12.87% |
| 2012-06-30 | $4.33B | $33.78B | 13.33% |
| 2012-03-31 | $4.27B | $31.99B | 13.30% |
| 2011-12-31 | $4.39B | $31.75B | 13.60% |
| 2011-09-30 | $4.66B | $32.34B | 14.42% |
| 2011-06-30 | $4.75B | $32.47B | 14.67% |
| 2011-03-31 | $4.87B | $32.52B | 15.20% |
| 2010-12-31 | $4.77B | $31.96B | 14.94% |
| 2010-09-30 | $8.35B | $32.58B | 25.88% |
| 2010-06-30 | $8.34B | $31.13B | 26.11% |
| 2010-03-31 | $8.28B | $32.15B | 25.99% |
| 2009-12-31 | $7.85B | $33.20B | 25.07% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $77.846B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.339B | 25.95 |
| CVS Health (CVS) | United States | $80.708B | 10.03 |
| Cencora (COR) | United States | $57.726B | 20.08 |
| DiDi Global (DIDIY) | China | $28.851B | 30.65 |
| Labcorp Holdings (LH) | United States | $20.589B | 16.70 |
| Natera (NTRA) | United States | $20.264B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $12.835B | 0.00 |
| Solventum (SOLV) | United States | $12.635B | 13.38 |
| ICON (ICLR) | Ireland | $11.632B | 10.81 |
| Revvity (RVTY) | United States | $11.186B | 19.25 |
| Viatris (VTRS) | United States | $10.657B | 3.66 |
| Medpace Holdings (MEDP) | United States | $9.049B | 24.03 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.446B | 37.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.988B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.610B | 14.91 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.902B | 37.73 |
| Alignment Healthcare (ALHC) | United States | $2.649B | 0.00 |
| Concentras Parent (CON) | United States | $2.522B | 14.58 |
| Organon (OGN) | United States | $2.503B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.296B | 88.43 |
| Progyny (PGNY) | United States | $1.973B | 43.43 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Premier (PINC) | United States | $1.730B | 13.13 |
| Ardent Health (ARDT) | United States | $1.718B | 7.32 |
| GoodRx Holdings (GDRX) | United States | $1.700B | 34.00 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.263B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.101B | 8.38 |
| CareDx (CDNA) | United States | $1.069B | 16.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.754B | 7.06 |
| InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
| Nutex Health (NUTX) | United States | $0.578B | 8.75 |
| Embecta (EMBC) | United States | $0.570B | 3.84 |
| SBC Medicals (SBC) | United States | $0.543B | 0.00 |
| So-Young (SY) | China | $0.530B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Omada Health (OMDA) | $0.476B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.368B | 0.00 |
| Enhabit (EHAB) | United States | $0.346B | 28.50 |
| Performant Healthcare (PHLT) | United States | $0.318B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |